October 9, 2015

The drug can now be used on patients whose non-small cell lung cancer metastasized while undergoing platinum-based chemotherapy or afte

October 7, 2015

Onco360 on Wednesday announced that it has been selected by Taiho Oncology as a limited distribution pharmacy network participant for Lonsurf (trifluridine and tipiracil). 

October 6, 2015

PharMEDium is a provider of customized outsourced compounded sterile preparations that meet specific hospital and physician clinical needs.

October 6, 2015

Each director brings relevant experience to the board, including expertise in the pharmaceutical manufacturing industry and insights into the dynamics and governance of a growing company.

October 5, 2015

Two Dutch pharmacy associations have presented a plan suggesting that widespread pharmacogenomics might be available by 2020. 

October 5, 2015

So far in 2015, there have bee 221,200 new cases of lung cancer and 158,040 deaths from the illness, according to the National Cancer Institute.

October 2, 2015

Cohen had more than 30 years’ experience working in pharmacy- and specialty pharmacy-related organizations, and was known in the field as an advocate and visionary.

October 1, 2015

Teva is acquring Rimsa, a pharmaceutical manufacturer and distributor based in one of the world's top emerging markets. 

September 30, 2015

NASP on Thursday announced that it had elected new leadership, established advisory committees for stakeholders and unveiled its new Center for Specialty Pharmacy Education.

September 29, 2015

Avalere Health’s Mike Johnsrud moderated a panel of leading stakeholders in the specialty pharmacy arena at an exclusive National Community Pharmacists Association day-long forum that explored specialty pharmacy as a viable and promising business model for entrepreneurial independent pharmacists. DSNTV was on hand to capture the highlights of that panel in this video, including insights from Diplomat Pharmacy’s Ela Lourido and H.D. Smith Specialty Solutions’ Tom Doyle.

September 25, 2015

Health benefit plan cost trend rates for 2016 will increase for most medical plan options and increase substantially for prescription drug coverage to double-digit rates, according to forecasts compiled in the 2016 Segal Health Plan Cost Trend Survey, Segal’s nineteenth annual survey of health plan cost trends. Trend is the forecast of annual gross per capita claims cost increases.

September 24, 2015

CVS Health has committed $10 million to SU2C over three years, supported by an annual in-store campaign. 

September 23, 2015

This summer independent pharmacists traveled from around the nation to the Washington, D.C., area for an exclusive National Community Pharmacists Association forum on the promise of specialty pharmacy. Drug Store News captured the highlights of that day that not only confirmed that community pharmacy can play a crucial role in the delivery of specialty medicines, but also provided a road map for independents interested in a specialty practice.

September 23, 2015

The Food and Drug Administration on Wednesday announced the approval of Taiho Oncology’s Lonsurf (trifluridine and tipiracil).

September 22, 2015

Keveyis was recently approved for the treatment of primary hyperkalemic and hypokalemic periodic paralysis, a group of rare hereditary disorders that cause episodes of muscle weakness or paralysis. 

September 16, 2015

Care Advantage provides more than 70 therapies and is currently authorized to distribute in all 50 states, districts and territories in the U.S.

September 11, 2015

Repatha is one in a new class of cholesterol medications called PSCK9 (proprotein convertase substilisin kexin type 9) inhibitors, which are potentially an alternative to statins.

September 11, 2015

Mission Pharmacal announced Friday that it would be relaunching its Lithostat (acetohydroxamic acid) kidney stones treatment.

September 10, 2015

The acquisition of Diplomat's compounding pharmacy assets by Restore Health enables Diplomat to continue their singular focus on specialty pharmacy, the companies stated. 

September 10, 2015

A new report from the Pharmaceutical Research and Manufacturers of America is highlighting the large volume of cancer medicines and vaccines that are currently being developed, as well as the impact innovations have had on cancer death rates. 

September 10, 2015

Purdue Pharma this week announced that it had VM902A, acquired an allosteric selective tropmyosin receptor kinase A (TrkA) inhibitor, from VM Pharma.

September 3, 2015

 The drug, a biosimilar version of Amgen’s Neupogen, is the first biosimilar drug to launch in the U.S.

September 1, 2015

The company said the patch is a potential solution for the 73% of migraine sufferers who experience nausea with their migraines. 

August 25, 2015

Amneal Pharmaceuticals announced Tuesday that it would be opening a new biosciences unit, that will be focused on commercializing specialty pharmaceuticals.